- Title: Subtitle
- A phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas
- Creators
- Mark Agulnik - Northwestern UniversityNisha Anjali Mohindra - Northwestern Memorial HospitalMohammed M. Milhem - University of IowaSteven Attia - Mayo Clinic in FloridaSteven Ian Robinson - Mayo ClinicAlfred Rademaker - Northwestern UniversitySusan E. Abbinanti - Northwestern UniversityRasima Cehic - Northwestern UniversityCatherine Humphreys - Northwestern UniversityBethany Prudner - Washington University in St. LouisScott H. Okuno - Mayo ClinicBrian Andrew Van Tine - Washington University in St. Louis
- Resource Type
- Abstract
- Publication Details
- Journal of clinical oncology, Vol.36(15_suppl), pp.11550-11550
- DOI
- 10.1200/JCO.2018.36.15_suppl.11550
- ISSN
- 0732-183X
- eISSN
- 1527-7755
- Language
- English
- Date published
- 05/20/2018
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Internal Medicine
- Record Identifier
- 9984363457902771
Abstract
A phase II study of pazopanib with oral topotecan in patients with metastatic and non-resectable soft tissue and bone sarcomas
Journal of clinical oncology, Vol.36(15_suppl), pp.11550-11550
05/20/2018
DOI: 10.1200/JCO.2018.36.15_suppl.11550
Details
Metrics
10 Record Views